Skip to main content

Media

Healthcare Professionals Opens in new tab

Financial Results Opens in new tab

Contact Us

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

About Us
About Us

We strive to improve the health of humans and animals - for generations. We work together with integrity and are guided by a shared purpose that defines who we are and what we do.

Section Overview

About Us

Section Overview

Corporate Profile

Go to Section

Board of Management

Company Culture

Go to Section

Our FOCUS

Diversity, Equity and Inclusion

Sustainable Development

Go to Section

Our Commitment

MORE HEALTH

MORE POTENTIAL

MORE GREEN

Our Stories

History

Sites Around the World

Ethics and Compliance

Go to Section

Speak Up – Compliance Hotline

Purchasing
Human Health
Human Health

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

Section Overview

Human Health

Section Overview

Heart Diseases

Go to Section

Heart Failure

Hypertension

Atrial Fibrillation

Stroke

Metabolic Diseases

Go to Section

Diabetes

Obesity

MASH

Chronic Kidney Disease

Cancer

Go to Section

Lung Cancer

Gastrointestinal Cancers

Across Cancer Types

Empowering Patients

Living With Cancer

Lung Diseases

Go to Section

Pulmonary Fibrosis

COPD & Asthma

Scleroderma

Skin and Inflammatory Diseases

Go to Section

GPP

Hidradenitis suppurativa (HS)

Mental Health

Go to Section

Schizophrenia

Depression

Retinal Diseases

Our Responsibility

Go to Section

Patient Centricity

Patient Safety

Products
Animal Health
Animal Health

As a global leader in the animal health industry, we are working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals.

Section Overview

Animal Health

Section Overview

Trends & Insights

Companion Animals & Horses

Go to Section

Pets

Horses

Veterinary Public Health

Livestock

Go to Section

Ruminants

Swine

Poultry

Our Responsibility

Products
Science & Innovation
Science & Innovation

Every day our scientists are charting new territory and continuing our commitment to innovation that has created exceptional medicines that have changed the lives of millions of patients.

Section Overview

Science & Innovation

Section Overview

Human Health Innovation

Go to Section

Clinical Pipeline

Science Focus

Fostering Science

Grass Roots

Science Stories

Clinical Studies

Animal Health Innovation

Go to Section

Therapeutics

Parasiticides

Vaccines

The Research Process
Partnering
Partnering

We embrace the power of partnership and diversity of minds across the life-science and animal health communities to realize even more innovation and incubate new ideas.

Section Overview

Partnering

Section Overview

Boehringer Ingelheim BioXcellence

Go to Section

Our Services

Our Global Network

Microbial Expertise

Newsroom

Contact BioXcellence

Human Health Partnering

Go to Section

Connect with Us

Partnering Interests

Partnering Culture

What Our Partners Say

Animal Health Partnering

Go to Section

Meet our Team

Partnering Interests
Careers
Careers

Together with you, we have the power to transform lives. The talent, skills, and collaboration of our people power our ability to improve the health and lives of humans and animals worldwide.

Join our team

Careers

Join our team

Explore our company

Discover our careers

See our Locations

How to apply

Get in touch

FAQ

Search and apply
Media
Healthcare Professionals Opens in new tab
Financial Results Opens in new tab
Contact Us

Boehringer Ingelheim

Nerandomilast (BI 1015550)

Phase 2
Indication: Systemic Sclerosis

This compound is under investigation, further information will be available soon.

Home
Nerandomilast (BI 1015550)

Follow us

Facebook
Youtube
Instagram
LinkedIn

Sitemap

About Us

Our Focus

Products

Stay Connected

Boehringer Ingelheim

Accessibility Statement
Terms of Use
Imprint
Data Privacy

© 2010-2024 Boehringer Ingelheim International GmbH. All rights reserved.